Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 129 100 KRW 0.08% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Relative Value

The Relative Value of one Daewoong Pharma stock under the Base Case scenario is 199 917.53 KRW. Compared to the current market price of 129 100 KRW, Daewoong Pharma is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
199 917.53 KRW
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
70
Median 3Y
1.1
Median 5Y
1.2
Industry
2.5
Forward
1.1
vs History
68
vs Industry
34
Median 3Y
25.7
Median 5Y
25.7
Industry
21.9
Forward
22.2
vs History
7
vs Industry
34
Median 3Y
17.6
Median 5Y
19.3
Industry
16.5
vs History
47
vs Industry
6
Median 3Y
44
Median 5Y
37.5
Industry
23.6
vs History
68
vs Industry
43
Median 3Y
2.1
Median 5Y
2.4
Industry
2.1
vs History
65
vs Industry
70
Median 3Y
1.2
Median 5Y
1.3
Industry
2.6
Forward
1.2
vs History
73
vs Industry
70
Median 3Y
2.4
Median 5Y
3
Industry
5.2
vs History
80
vs Industry
37
Median 3Y
10.6
Median 5Y
14.7
Industry
13.3
Forward
8.1
vs History
85
vs Industry
35
Median 3Y
14.8
Median 5Y
20.9
Industry
16.6
Forward
10.6
vs History
6
vs Industry
34
Median 3Y
18.7
Median 5Y
21.2
Industry
15.6
vs History
vs Industry
10
Median 3Y
35.6
Median 5Y
34.3
Industry
19.1
vs History
71
vs Industry
59
Median 3Y
1.1
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Daewoong Pharma Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Daewoong Pharma
KRX:069620
1.5T KRW 1 14.3 8.6 11.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
KR
Daewoong Pharma
KRX:069620
Average P/E: 30.2
14.3
9%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top